Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

InVivoMAb Anti-Mouse TIGIT Antibody (10A7)


View Antibody details

InVivoMAb Anti-Mouse TIGIT Antibody (1B4)


View Antibody details

InVivoMAb Anti-Mouse TIGIT Antibody (4D4)


View Antibody details

InVivoMAb Anti-Mouse TIGIT&PD-L1/B7-H1 Antibody (Iv0247)


View Antibody details

InVivoMAb Anti-Mouse TIGIT&PD-L1/B7-H1 Antibody (Iv0258)


View Antibody details

InVivoMAb Anti-Mouse TIM-3 Antibody (B8.2C12)


View Antibody details

InVivoMAb Anti-Mouse TRANCE/TNFSF11/RANK L Antibody (7C6)


View Antibody details

InVivoMab Anti-Mouse TYRP1 & CD3 epsilon Antibody (145-2C11 & TA99)


View Antibody details

InVivoMAb Anti-Mouse TYRP1&CD3 epsilon Antibody (Iv0236)


View Antibody details

InVivoMAb Anti-Mouse TYRP1&CD47 Antibody (Iv0237)


View Antibody details